Images from the Cobroxin Bottling Plant

Images from the Cobroxin Bottling Plant
Posted on Jan 24th, 2010 by Nutra Pharma Corporate Communications on NPC Blog

To see article with images please go to http://www.nutrapharma.com/blog/

Last week, we spent time visiting the Cobroxin bottling facility. While we were there, we took a few photos to share on our blog. We hope you enjoy the following images.

Most of the packaging process is automated, including the labeling of the bottles. In this photo, you can see the labeling machine printing the labels to go on the Cobroxin Oral Spray bottles.
At Nutra Pharma, we continually strive to manufacture the highest quality products.

In this photo you can see several members of our bottler’s quality assurance team. Their role at the bottling facility is to ensure that every bottle of Cobroxin meets or exceeds our strict quality standards.

Once the bottles of Cobroxin are filled, labeled and individually shrink wrapped, they are then grouped into cartons containing 12 bottles and placed on pallets for immediate shipment. As you can see from the above photo, we even custom print our shipping cartons to include the Cobroxin logo.

About Nutra Pharma Corp.
Nutra Pharma Corp. is a biopharmaceutical company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases. Nutra Pharma Corp. through its subsidiaries carries out basic drug discovery research and clinical development and also seeks strategic licensing partnerships to reduce the risks associated with the drug development process. The Company's subsidiary, ReceptoPharm, Inc., is developing these technologies for the production of drugs for HIV and Multiple Sclerosis ("MS"). The Company's subsidiary, Designer Diagnostics, is engaged in the research and development of diagnostic test kits designed to be used for the rapid identification of infectious diseases such as Paratuberculosis (para-TB) and Mycobacterium avium-intracellulare (MAI). Nutra Pharma continues to identify and acquire intellectual property and companies in the biotechnology arena.
For more information about Cobroxin, visit http://www.cobroxin.com/.

http://www.nutrapharma.com/
http://www.cobroxin.com/

Undiscovered Equities is currently offering a complimentary trial subscription.
To view our newsletter on a complimentary trial basis and take advantage of our other services go to http://www.undiscoveredequities.com/ and join our email list on our home page.

Kevin McKnight
1-800-404-8982
Undiscovered Equities, Inc.
101 Plaza Real, Suite 212
Boca Raton, FL 33432
http://www.undiscoveredequities.com/

disclaimer